Europe Insomnia Therapeutics Market Report 2018

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Insomnia Therapeutics Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Drugs Market Performance (Volume)
  • 2.1.2 Devices Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Drugs Market Performance (Value)
  • 2.1.2 Devices Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Prescription Market Performance (Volume)
  • 3.1.2 Over-the-Counter(OTC) Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Takeda Pharmaceutical Co. Ltd.
  • 4.1.1 Takeda Pharmaceutical Co. Ltd. Profiles
  • 4.1.2 Takeda Pharmaceutical Co. Ltd. Product Information
  • 4.1.3 Takeda Pharmaceutical Co. Ltd. Insomnia Therapeutics Business Performance
  • 4.1.4 Takeda Pharmaceutical Co. Ltd. Insomnia Therapeutics Business Development and Market Status
• 4.2 Vanda Pharmaceuticals
  • 4.2.1 Vanda Pharmaceuticals Profiles
  • 4.2.2 Vanda Pharmaceuticals Product Information
  • 4.2.3 Vanda Pharmaceuticals Insomnia Therapeutics Business Performance
  • 4.2.4 Vanda Pharmaceuticals Insomnia Therapeutics Business Development and Market Status
• 4.3 Merck & Co, Inc.
  • 4.3.1 Merck & Co, Inc. Profiles
  • 4.3.2 Merck & Co, Inc. Product Information
  • 4.3.3 Merck & Co, Inc. Insomnia Therapeutics Business Performance
  • 4.3.4 Merck & Co, Inc. Insomnia Therapeutics Business Development and Market Status
• 4.4 Pfizer Inc.
  • 4.4.1 Pfizer Inc. Profiles
  • 4.4.2 Pfizer Inc. Product Information
  • 4.4.3 Pfizer Inc. Insomnia Therapeutics Business Performance
  • 4.4.4 Pfizer Inc. Insomnia Therapeutics Business Development and Market Status
• 4.5 Teva Pharmaceutical Industries Ltd.
  • 4.5.1 Teva Pharmaceutical Industries Ltd. Profiles
  • 4.5.2 Teva Pharmaceutical Industries Ltd. Product Information
  • 4.5.3 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Business Performance
  • 4.5.4 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Business Development and Market Status
• 4.6 Mylan N. V.
  • 4.6.1 Mylan N. V. Profiles
  • 4.6.2 Mylan N. V. Product Information
  • 4.6.3 Mylan N. V. Insomnia Therapeutics Business Performance
  • 4.6.4 Mylan N. V. Insomnia Therapeutics Business Development and Market Status
• 4.7 Sumitomo Dainippon Pharma Co., Ltd.
  • 4.7.1 Sumitomo Dainippon Pharma Co., Ltd. Profiles
  • 4.7.2 Sumitomo Dainippon Pharma Co., Ltd. Product Information
  • 4.7.3 Sumitomo Dainippon Pharma Co., Ltd. Insomnia Therapeutics Business Performance
  • 4.7.4 Sumitomo Dainippon Pharma Co., Ltd. Insomnia Therapeutics Business Development and Market Status
• 4.8 Sanofi
  • 4.8.1 Sanofi Profiles
  • 4.8.2 Sanofi Product Information
  • 4.8.3 Sanofi Insomnia Therapeutics Business Performance
  • 4.8.4 Sanofi Insomnia Therapeutics Business Development and Market Status
• 4.9 Paratek Pharmaceuticals;and Ebb Therapeutics
  • 4.9.1 Paratek Pharmaceuticals;and Ebb Therapeutics Profiles
  • 4.9.2 Paratek Pharmaceuticals;and Ebb Therapeutics Product Information
  • 4.9.3 Paratek Pharmaceuticals;and Ebb Therapeutics Insomnia Therapeutics Business Performance
  • 4.9.4 Paratek Pharmaceuticals;and Ebb Therapeutics Insomnia Therapeutics Business Development and Market Status

5 Market Performance for Manufacturers

• 5.1 Europe Insomnia Therapeutics Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Europe Insomnia Therapeutics Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Europe Insomnia Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Europe Insomnia Therapeutics Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 Germany Market Performance for Manufacturers
  • 6.1.1 Germany Insomnia Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 Germany Insomnia Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 Germany Insomnia Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 Germany Insomnia Therapeutics Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 UK Market Performance for Manufacturers
  • 6.2.1 UK Insomnia Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 UK Insomnia Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 UK Insomnia Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 UK Insomnia Therapeutics Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 France Market Performance for Manufacturers
  • 6.3.1 France Insomnia Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 France Insomnia Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 France Insomnia Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 France Insomnia Therapeutics Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 Russia Market Performance for Manufacturers
  • 6.4.1 Russia Insomnia Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 Russia Insomnia Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 Russia Insomnia Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 Russia Insomnia Therapeutics Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration
• 6.5 Benelux Market Performance for Manufacturers
  • 6.5.1 Benelux Insomnia Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.5.2 Benelux Insomnia Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.5.3 Benelux Insomnia Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
  • 6.5.4 Benelux Insomnia Therapeutics Gross Margin of Manufacturers 2013-2018
  • 6.5.5 Market Concentration
• 6.6 Italy Market Performance for Manufacturers
  • 6.6.1 Italy Insomnia Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.6.2 Italy Insomnia Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.6.3 Italy Insomnia Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
  • 6.6.4 Italy Insomnia Therapeutics Gross Margin of Manufacturers 2013-2018
  • 6.6.5 Market Concentration
• 6.7 Spain Market Performance for Manufacturers
  • 6.7.1 Spain Insomnia Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.7.2 Spain Insomnia Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.7.3 Spain Insomnia Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
  • 6.7.4 Spain Insomnia Therapeutics Gross Margin of Manufacturers 2013-2018
  • 6.7.5 Market Concentration
• 6.8 Market Performance for Manufacturers
  • 6.8.1 Insomnia Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.8.2 Insomnia Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.8.3 Insomnia Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
  • 6.8.4 Insomnia Therapeutics Gross Margin of Manufacturers 2013-2018
  • 6.8.5 Market Concentration

7 Europe Insomnia Therapeutics Market Performance (Sales Point)

• 7.1 Europe Insomnia Therapeutics Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 Europe Insomnia Therapeutics Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 Europe Insomnia Therapeutics Price (USD/Unit) by Regions 2013-2018
• 7.4 Europe Insomnia Therapeutics Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 Europe Insomnia Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 Germany Insomnia Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 UK Insomnia Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 France Insomnia Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 Russia Insomnia Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.6 Benelux Insomnia Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.7 Italy Insomnia Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Spain Insomnia Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Spain Insomnia Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Prescription Industry
• 11.2 Over-the-Counter(OTC) Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 Europe Insomnia Therapeutics Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 Europe Insomnia Therapeutics Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 Germany Insomnia Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 UK Insomnia Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 France Insomnia Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 Russia Insomnia Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 Benelux Insomnia Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 Italy Insomnia Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Spain Insomnia Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Prescription Sales and and Growth Rate 2019-2024
  • 12.4.3 Over-the-Counter(OTC) Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 Europe Insomnia Therapeutics Price (USD/Unit) Trend 2019-2024
  • 12.5.2 Europe Insomnia Therapeutics Gross Profit Trend 2019-2024

13 Conclusion